One in four cases of colorectal cancer diagnosed within two years of a negative screening result
2/25/2016

One in four cases of colorectal cancer (CRC) detected in a guiac faecal occult blood testing (gFOBT) programme are diagnosed within two years of a negative screening result, a study in the UEG...

Searching for cancer's fingerprints gives clues to tumour growth
2/25/2016

A University of Manchester study has shed light on a chain of events that allows tumour cells to thrive in tough environments, identifying potential new ways to diagnose and treat cancer.

Black men more likely to undergo PSA screening than non-hispanic whites
2/25/2016

African American men have the highest rate of prostate cancer and shorter survival time compared to other racial/ethnic groups in the U.S.

One in four cases of colorectal cancer diagnosed within two years of a negative screening result
2/25/2016

One in four cases of colorectal cancer (CRC) detected in a guiac faecal occult blood testing (gFOBT) programme are diagnosed within two years of a negative screening result, a study in the UEG...

Moffitt develops novel cancer treatment to inhibit chemo-resistance
2/25/2016

Despite numerous advances in oncology since the War on Cancer began, many patients develop resistance to standard therapies and eventually relapse.

Moffitt develops novel cancer treatment to inhibit chemo-resistance
2/25/2016

Despite numerous advances in oncology since the War on Cancer began, many patients develop resistance to standard therapies and eventually relapse.

Study shows financial engineering could make life-saving drugs more available, affordable
2/25/2016

At a time when breakthrough therapies for certain cancers, hepatitis C, and rare diseases remain out of reach for many patients due to their prohibitive cost, new research by Dana-Farber Cancer...

Malignant brain tumors most common cause of cancer deaths in adolescents and young adults
2/25/2016

American Brain Tumor Association funds first comprehensive study of 15-39 year-old population.

Breaching blood-brain barrier enables chemotherapy to zap glioblastoma
2/25/2016

Laser technology has opened the blood-brain barrier long enough to both kill cancer cells and deliver chemotherapy, preventing tumor growth in 12 out of 14 cases of glioblastoma.

Metabolism 'rewiring' leads to aggressive lung cancers
2/24/2016

Scientists have discovered that lung cancers with extra copies of a cancer causing gene-defect 'rewire' their energy supply, helping them to survive and making them more likely to spread.